Early Diagnosis of ARDS in Mechanically Ventilated Patient Using LUS Score in Comparison With CT
Launched by TANTA UNIVERSITY · May 6, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to quickly and accurately diagnose Acute Respiratory Distress Syndrome (ARDS) in patients who are expected to be on a ventilator for more than 24 hours. Researchers want to see how well a method called Lung Ultrasound Score (LUS) works compared to a traditional imaging test called a CT scan. ARDS is a serious lung condition that can develop after certain injuries or illnesses, and quick diagnosis can be critical for treatment.
To participate in this study, patients need to be at least 21 years old and are expected to need mechanical ventilation for over a day. They should also be suspected of having ARDS based on specific medical criteria. Some patients may not be eligible if they have certain pre-existing lung conditions or other complications. If someone joins the trial, they will undergo both the lung ultrasound and CT scan as part of their routine care. This research aims to improve how quickly and effectively ARDS is diagnosed, potentially leading to better treatment outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged more than 21 years old of both sexes .
- • Patients who are expected to be mechanically ventilated more than 24 h .
- • Patients who are suspected to be Acute Respiratory Distress Syndrome according to Berlin definition which consists of clinical criteria and with precipitating factors which starts within 1 week of known insult as in trauma patients with lung contusions.
- Exclusion Criteria:
- • Patient's first guardian who refuse the inclusion in the study .
- • History of pre-existing lung disease ( tumors, interstitial lung diseases)
- • In cases of volume overload.
- • Patients with acute kidney injuiry or renal failure
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, , Egypt
Patients applied
Trial Officials
Roaa Elshamy, MSc
Principal Investigator
Tanta University
Roaa Elshamy
Principal Investigator
Tanta University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported